LAB - STANDARD BIOTOOLS INC.

1.16
-0.070   -6.034%

Share volume: 710,836
Last Updated: 04-25-2025
Measuring And Control Equipment/Lab Analytical Instruments: -0.06%

PREVIOUS CLOSE
CHG
CHG%
$1.23
-0.07
-0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
24%
Profitability 0%
Dept financing 6%
Liquidity 75%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-8.66%
1 Month
1.75%
3 Months
-0.85%
6 Months
-0.85%
1 Year
-0.85%
2 Year
-0.85%
Key data
Stock price
$1.16
P/E Ratio 
N/A
DAY RANGE
$1.13 - $1.26
EPS 
N/A
52 WEEK RANGE
$0.97 - $1.33
52 WEEK CHANGE
-$0.85
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$817,635
AVERAGE 30 VOLUME 
$1,195,289
Company detail
CEO: Michael Egholm
Region: US
Website: fluidigm.com
Employees: 620
IPO year: 2011
Issue type:
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems. The company also sells single cell microfluidics that comprise C1 systems; preparatory analytical instruments; and software solutions.

Recent news
loading